Potential conflict of interest: Stock Ownership – R.K.J., SynDevRx, Enlight, XTuit; Employment or Leadership Position – none; Consulting – R.K.J., Enlight, Noxxon, Zyngenia, D.G.D., Hexal/Sandoz, A.X.Z., Sanofi-Aventis, Eisai, Exelixis; Advisory arrangements – T.R., MSD, Gilead; Speakers' Bureau – none; Grants/Contracts: Research – T.R., Roche, Phenex, MSD, Gilead, Janssen, R.K.J., Dyax, MedImmune, Roche, A.X.Z., Bayer, Onyx, Lilly; Grants/Contracts: Unrestricted – none; Travel Grants – T.R., Roche, MSD, Gilead, Janssen; Intellectual Property Rights – none; Other Interests – R.K.J., Board of Directors of XTuit and Boards of Trustees of H&Q Healthcare Investors and H&Q Life Sciences Investors.
Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal-derived factor 1 alpha/C-X-C receptor type 4 axis and myeloid differentiation antigen–positive myeloid cell infiltration in mice
Version of Record online: 18 FEB 2014
© 2014 by the American Association for the Study of Liver Diseases
Volume 59, Issue 4, pages 1435–1447, April 2014
How to Cite
Chen, Y., Huang, Y., Reiberger, T., Duyverman, A. M., Huang, P., Samuel, R., Hiddingh, L., Roberge, S., Koppel, C., Lauwers, G. Y., Zhu, A. X., Jain, R. K. and Duda, D. G. (2014), Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal-derived factor 1 alpha/C-X-C receptor type 4 axis and myeloid differentiation antigen–positive myeloid cell infiltration in mice. Hepatology, 59: 1435–1447. doi: 10.1002/hep.26790
This study was supported by the National Institutes of Health grants no.: P01-CA080124, R01-CA159258, R21-CA139168, R01-CA126642 and National Cancer Institute/Proton Beam Federal Share Program awards (to D.G.D. and R.K.J.), by the American Cancer Society grant 120733-RSG-11-073-01-TBG (to D.G.D.) and by a Max Kade Fellowship (to T.R.).
- Issue online: 24 MAR 2014
- Version of Record online: 18 FEB 2014
- Accepted manuscript online: 14 NOV 2013 09:49PM EST
- Manuscript Accepted: 3 OCT 2013
- Manuscript Received: 14 JUL 2013
- National Institutes of Health . Grant Number: P01-CA080124
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.